Choisy le Roi, France

Catherine Souaille

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Catherine Souaille

Introduction

Catherine Souaille is a prominent inventor based in Choisy le Roi, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target cancer-related proteins. With a total of 9 patents to her name, her work has garnered attention for its potential therapeutic applications.

Latest Patents

Among her latest patents are two notable inventions. The first is related to 7-substituted aza-indazoles, which are compounds that modulate the activity of proteins, especially kinases. This patent details the production methods and uses of these compounds as medicaments, particularly as anticancer agents. The second patent focuses on substituted pyrazolopyridines, which also have applications in medicine, specifically as anticancer agents. This patent outlines the methods for their production and the compositions containing these compounds.

Career Highlights

Catherine has worked with leading pharmaceutical companies, including Aventis Pharma S.A. and Sanofi-Aventis Deutschland GmbH. Her experience in these organizations has allowed her to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Throughout her career, Catherine has collaborated with notable professionals in her field, including Fabrice Viviani and Michel Tabart. These collaborations have further enriched her research and innovation efforts.

Conclusion

Catherine Souaille's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patents and collaborations highlight her commitment to advancing cancer treatment through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…